Learn More
Apexbio Technology LLC Risedronate 105462-24-6 1g

Supplier: Apexbio Technology LLC B18261000
Risedronate (CAS 105462-24-6) is a small-molecule inhibitor targeting farnesyl pyrophosphate (FPP) synthase It is designed to inhibit this enzyme in the mevalonate pathway thereby reducing osteoclast prenylation and function Risedronate exerts its biological activity primarily through selective binding to hydroxyapatite surfaces in bone leading to decreased osteoclastic activity and suppressed bone resorption Based on these pharmacological properties Risedronate holds research potential in the study of osteoclast biology metabolic bone disorders osteoporosis and bone remodeling processes
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.